Gain Therapeutics, Inc. - COM (GANX)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
1.34M
Holdings value Q3 2024
$2.4M
Value change Q3 2024
-$2.12M
Grand Portfolio weight change Q3 2024
0%
Number of holders
18
Number of buys Q3 2024
6
Number of sells Q3 2024
-14
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.34M $2.4M -$2.12M $1.78 19
2024 Q2 3.04M $3.89M +$108K $1.28 27
2024 Q1 1.87M $7.04M +$1.32M $3.77 26
2023 Q4 1.54M $5.04M +$81.8K $3.27 24
2023 Q3 1.52M $4.95M +$797K $3.28 24
2023 Q2 1.27M $5.68M +$521K $4.48 24
2023 Q1 1.15M $5.54M +$343K $4.82 22
2022 Q4 1.21M $3.78M -$18.5K $3.13 21
2022 Q3 1.21M $3.95M +$450K $3.26 21
2022 Q2 1.07M $3.87M -$337K $3.60 16
2022 Q1 1.16M $4.75M +$363K $4.09 16
2021 Q4 1.06M $5.71M +$813K $5.39 18
2021 Q3 893K $6.65M -$472K $7.45 13
2021 Q2 894K $8.95M -$1.89M $10.00 12
2021 Q1 1.01M $15M +$15M $14.92 12